What is Lifesci Capital’s Forecast for CRBP Q1 Earnings?
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) – Investment analysts at Lifesci Capital boosted their Q1 2025 earnings per share estimates for shares of Corbus Pharmaceuticals in a research note issued on Tuesday, March 11th. Lifesci Capital analyst M. Belghiti now expects that the biopharmaceutical company will post earnings of ($2.74) per share for […]
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) – Investment analysts at Lifesci Capital boosted their Q1 2025 earnings per share estimates for shares of Corbus Pharmaceuticals in a research note issued on Tuesday, March 11th. Lifesci Capital analyst M. Belghiti now expects that the biopharmaceutical company will post earnings of ($2.74) per share for […]
